QT-019C
IIT2025138
Phase 1 mab active
Quick answer
QT-019C for SLE - Systemic Lupus Erythematosus is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- SLE - Systemic Lupus Erythematosus
- Phase
- Phase 1
- Modality
- mab
- Status
- active